Literature DB >> 33454844

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?

Gábor Tigyi1,2, Mélanie A Dacheux3, Kuan-Hung Lin3, Junming Yue4, Derek Norman3, Zoltán Benyó5, Sue Chin Lee3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33454844      PMCID： PMC7897189          DOI： 10.1007/s10555-021-09955-5

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  6 in total

1.  Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.

Authors:  Raphael Leblanc; Sue-Chin Lee; Marion David; Jean-Claude Bordet; Derek D Norman; Renukadevi Patil; Duane Miller; Debashish Sahay; Johnny Ribeiro; Philippe Clézardin; Gabor J Tigyi; Olivier Peyruchaud
Journal:  Blood       Date:  2014-10-02       Impact factor: 22.113

2.  A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression.

Authors:  Francesca R Auciello; Vinay Bulusu; Chet Oon; Jacqueline Tait-Mulder; Mark Berry; Sohinee Bhattacharyya; Sergey Tumanov; Brittany L Allen-Petersen; Jason Link; Nicholas D Kendsersky; Esmee Vringer; Michelle Schug; David Novo; Rosa F Hwang; Ronald M Evans; Colin Nixon; Craig Dorrell; Jennifer P Morton; Jim C Norman; Rosalie C Sears; Jurre J Kamphorst; Mara H Sherman
Journal:  Cancer Discov       Date:  2019-03-05       Impact factor: 39.397

3.  Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.

Authors:  Eun Jin Seo; Yang Woo Kwon; Il Ho Jang; Dae Kyoung Kim; Soo In Lee; Eun Jung Choi; Ki-Hyung Kim; Dong-Soo Suh; Jeong Hee Lee; Kyung Un Choi; Jae Won Lee; Hyuck Jun Mok; Kwang Pyo Kim; Hirotaka Matsumoto; Junken Aoki; Jae Ho Kim
Journal:  Stem Cells       Date:  2016-02-02       Impact factor: 6.277

Review 4.  Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.

Authors:  Gabor J Tigyi; Junming Yue; Derek D Norman; Erzsebet Szabo; Andrea Balogh; Louisa Balazs; Guannan Zhao; Sue Chin Lee
Journal:  Adv Biol Regul       Date:  2018-09-16

5.  LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti-PD-1 Therapy against Brain Tumors.

Authors:  Daisuke Eino; Yohei Tsukada; Hisamichi Naito; Yonehiro Kanemura; Tomohiro Iba; Taku Wakabayashi; Fumitaka Muramatsu; Hiroyasu Kidoya; Hideyuki Arita; Naoki Kagawa; Yasunori Fujimoto; Kazuhiro Takara; Haruhiko Kishima; Nobuyuki Takakura
Journal:  Cancer Res       Date:  2018-10-09       Impact factor: 12.701

6.  LPA5 Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling.

Authors:  Divij Mathew; Kimberly N Kremer; Pamela Strauch; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Front Immunol       Date:  2019-05-28       Impact factor: 7.561
  6 in total
  2 in total

Review 1.  Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.

Authors:  Souvik Banerjee; Suechin Lee; Derek D Norman; Gabor J Tigyi
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

Review 2.  The LPA3 Receptor: Regulation and Activation of Signaling Pathways.

Authors:  Karina Helivier Solís; M Teresa Romero-Ávila; Alejandro Guzmán-Silva; J Adolfo García-Sáinz
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.